CN102512517B - Traditional Chinese medicine composition for treating bone fracture - Google Patents
Traditional Chinese medicine composition for treating bone fracture Download PDFInfo
- Publication number
- CN102512517B CN102512517B CN 201110425232 CN201110425232A CN102512517B CN 102512517 B CN102512517 B CN 102512517B CN 201110425232 CN201110425232 CN 201110425232 CN 201110425232 A CN201110425232 A CN 201110425232A CN 102512517 B CN102512517 B CN 102512517B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- fracture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating bone fracture, composed of traditional Chinese medicine raw materials in the following parts by weight: 10-40 parts of lycopodium clavatum, 10-40 parts of garden balsam stem, 10-30 parts of angelica sinensis, 10-30 parts of radix paeoniae rubra, 10-30 parts of pseudo-ginseng, 5-20 parts of safflower carthamus, 5-20 parts of pawpaw, 5-25 parts of cassia twig, 5-25 parts of rhizoma drynariae, 5-25 parts of teasel root and 5-25 parts of caulis spatholobi. The traditional Chinese medicine composition disclosed by theinvention has the effects of invigorating blood circulation and removing stasis, relieving swelling and pain, reuniting fractured tendons and bones, tonifying liver and kidney, as well as tonifying qi and promoting blood circulation; and pain relief for the patient is obvious, porosis is rapid, and physiological healing period is advanced. The components of the traditional Chinese medicine composition disclosed by the invention are wide in medicine source, simple and convenient in preparation, mild in medicine property and without toxic and side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of fracture.
Background technology
In daily productive life, along with vehicle increases and the continuous generation of security incident gradually, the patient that fracture takes place also increases proportional.At present, treatment to general fracture patient is to adopt artificial elder generation with after the fracture site normotopia clinically, fix with steel wire or with steel plate, clamping plate, and then in the outside plaster fixation of using of affected part, bed is rested, and this method is to rely on the spontaneous recovery regeneration capacity of the human body of patient own that fracture site is engaged; Or obey blood circulation promoting medicine such as some similar YUNNAN BAIYAO again, purpose is to promote fracture to heal early or end logical antiinflammatory, there is the deficiency that healing stage is long, the patient suffering is many; Critically ill patient is generally taked open reduction internal fixation etc., painful big because performing the operation, the expense height, and majority is not accepted.
Union of fracture by three gradually progression finish, i.e. organization of hematoma phase, primary callus phase and callus are transformed the phase.The organization of hematoma phase: after the fracture, bone stump and the angiorrhexis of organizing on every side thereof are hemorrhage, the formation hematoma, a small amount of cortical bone of bone stump is downright bad because of ischemia, hematoma condensed into the blood clot that contains reticular fiber in 6～8 hours in hindering the back, blood capillary proliferation fibroblast then, phagocyte is invaded from all quarter, make hematoma machine formation fibrous connective tissue gradually, the osteoblast hypertrophy of inside and outside film, form the osteoid tissue parallel with the key longitudinal axis during to 3 weeks, fracture site is tentatively connected, be called fibrous callus.The primary callus phase: in the bone, the nephridioblast of adventitia inside and outside the broken ends of fractured bone, form osteoid tissue and gradually calcification form area of new bone, claim intramembranous ossification, both are close to interior (internal callus) of cortical bone, (external callus) two sides outward, the fibrous connective tissue that is formed by organization of hematoma between the broken ends of fractured bone, cartilage is changed in big portion, chondrocyte is through hyper-proliferative, degeneration, calcification and ossified be bone internalization bone, form the ring-type callus that comprises the callus in the pulp cavity and be sandwiched in interior external callus respectively, external callus, internal callus, the ring-type callus, the intracavity callus " is joined forces " fusion, and it is ossified fully, finish the primary callus phase, that is the clinical healing phase.Callus transforms the phase: be made up of the little fine strain of millet of bone of irregular arrangement, owe firm primary callus, along with the heavy burden of limbs, bone trabecula is grown along the stress axis, and queueing discipline and densification, this process are to remove and the osteoblast evolution by engulfing of osteoclast, form permanent bone and connect.
Chinese traditional treatment fracture method is to adopt symptomatic treatment in acute condition, the rule of relieving the primary symptom in a chronic case, and that tests is clinical, has curative effect preferably.
The Chinese traditional treatment fracture mainly is to carry out dialectical treatment at the above-mentioned different stage.The organization of hematoma phase: injury blood stasis swelling, blockage of main and collateral channels, the QI and blood retardance, this phase treatment is with blood circulation promoting and blood stasis dispelling, and circulation of qi promoting is dissipated as the master.The primary callus phase: congestive edema is most of to be absorbed, and this phase treatment is based on relieving pain by regulating nutrient QI, promoting tissue regeneration by removing blood stasis, reunion of bone.Callus is transformed the phase: by liver and kidney tonifying, fill blood, generate to promote more firm callus, and relaxing muscles and tendons and activating QI and blood in the collateral, make the adjacent joints of fractures can the freedom and flexibility motion, recover function in the past.
Summary of the invention
The purpose of this invention is to provide a kind ofly prepare conveniently, cost is low, evident in efficacy, the Chinese medicine composition of the treatment fracture that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of fracture is characterized in that: it is made up of following parts by weight of Chinese traditional medicine raw material: Herba Lycopodii 10-40 part, Herba speranskiae tuberculatae 10-40 part, Radix Angelicae Sinensis 10-30 part, Radix Paeoniae Rubra 10-30 part, Radix Notoginseng 10-30 part, Flos Carthami 5-20 part, Fructus Chaenomelis 5-20 part, Ramulus Cinnamomi 5-25 part, Rhizoma Drynariae 5-25 part, Radix Dipsaci 5-25 part, Caulis Spatholobi 5-25 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of fracture is characterized in that: it is made up of following parts by weight of Chinese traditional medicine raw material: 30 parts of Herba Lycopodiis, 30 parts of Herba speranskiae tuberculataes, 20 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Notoginseng, 12 parts on Flos Carthami, 12 parts of Fructus Chaenomeliss, 15 parts of Ramulus Cinnamomi, 15 parts of Rhizoma Drynariae, 15 parts of Radix Dipsacis, 15 parts of Caulis Spatholobis.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In the Chinese medicine composition of the present invention: Herba Lycopodii has the effect of expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral; Herba speranskiae tuberculatae has the effect of wind-expelling pain-stopping, relaxing muscles and tendons to promote blood circulation; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, the effect of loosening bowel to relieve constipation; Radix Paeoniae Rubra has the effect of clearing away heat and cooling blood, eliminating stasis to stop pain; Radix Notoginseng has the effect of hemostasis dissipating blood stasis, reducing swelling and alleviating pain; Flos Carthami has the effect of promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Fructus Chaenomelis has the effect of suppressing the hyperactive liver Shujin, stomach function regulating removing dampness; Ramulus Cinnamomi has the effect of warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Rhizoma Drynariae has the kidney invigorating bone strengthening, continuous effect of hindering pain relieving; Radix Dipsaci has the effect of invigorating the liver and kidney, bone and muscle strengthening, blood circulation regulating, continuous folding wound; Caulis Spatholobi returns liver, kidney channel, have enrich blood, invigorate blood circulation, the effect of collateral dredging.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, complement each other using, have synergism, play the effect of blood circulation and removing stasis, reducing swelling and alleviating pain, reunion of fractured tendons and bones, the liver and the kidney tonifying, tonifying QI to promote blood circulation altogether, make the patient remove the pain hardship unbearably of fracture, need not to obey again analgesic, callus formation is rapid, and the physiological healing phase obviously shifts to an earlier date, thereby reaches the purpose for the treatment of fracture.
The component of the present composition all adopts natural botanical herbs raw material, and its preparation is easy, and the medicine source is wide, and cost is low.The present invention follows the prescription principle of medication of the traditional Chinese medical science, and various component drug adopt the usefulness that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, toxic and side effects do not occur, and effective percentage reaches 100%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of fracture, it is made up of following Chinese medicine raw materials by weight proportion: Herba Lycopodii 30g, Herba speranskiae tuberculatae 30g, Radix Angelicae Sinensis 20g, Radix Paeoniae Rubra 20g, Radix Notoginseng 20g, Flos Carthami 12g, Fructus Chaenomelis 12g, Ramulus Cinnamomi 15g, Rhizoma Drynariae 15g, Radix Dipsaci 15g, Caulis Spatholobi 15g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of fracture, it is made up of following Chinese medicine raw materials by weight proportion: Herba Lycopodii 40g, Herba speranskiae tuberculatae 10g, Radix Angelicae Sinensis 15g, Radix Paeoniae Rubra 10g, Radix Notoginseng 25g, Flos Carthami 20g, Fructus Chaenomelis 5g, Ramulus Cinnamomi 10g, Rhizoma Drynariae 20g, Radix Dipsaci 10g, Caulis Spatholobi 5g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of fracture, it is made up of following Chinese medicine raw materials by weight proportion: Herba Lycopodii 20g, Herba speranskiae tuberculatae 20g, Radix Angelicae Sinensis 30g, Radix Paeoniae Rubra 15g, Radix Notoginseng 10g, Flos Carthami 5g, Fructus Chaenomelis 15g, Ramulus Cinnamomi 25g, Rhizoma Drynariae 10g, Radix Dipsaci 25g, Caulis Spatholobi 10g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of fracture, it is made up of following Chinese medicine raw materials by weight proportion: Herba Lycopodii 10g, Herba speranskiae tuberculatae 40g, Radix Angelicae Sinensis 25g, Radix Paeoniae Rubra 20g, Radix Notoginseng 15g, Flos Carthami 15g, Fructus Chaenomelis 20g, Ramulus Cinnamomi 5g, Rhizoma Drynariae 25g, Radix Dipsaci 10g, Caulis Spatholobi 25g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of fracture, it is made up of following Chinese medicine raw materials by weight proportion: Herba Lycopodii 25g, Herba speranskiae tuberculatae 15g, Radix Angelicae Sinensis 10g, Radix Paeoniae Rubra 30g, Radix Notoginseng 30g, Flos Carthami 10g, Fructus Chaenomelis 10g, Ramulus Cinnamomi 20g, Rhizoma Drynariae 5g, Radix Dipsaci 5g, Caulis Spatholobi 25g.
Chinese medicine composition in embodiment of the invention decocting method is routinely produced medicament, and concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, add water again and do not have about 5 centimetres of powder, decoct.Adopt intense fire to decoct at a simmer, slow fire boiling 20～30 minutes are used in the back of boiling; Second decocts, and decocts 15～20 minutes after water boils.Twice decoction extracting juice that removes slag merges.
A kind of Chinese medicine composition for the treatment of fracture, clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 60 examples, male 37 examples wherein, women 23 examples, 15～60 years old its age.
Two, usage and dosage: during clinical practice, the component in the compositions is taken the circumstances into consideration increase and decrease according to patient's body weight and age.This Chinese medicine composition potion on the one, the about 300ml of twice extracting juice of decocting divides sooner or later and takes for twice.
Three, criterion of therapeutical effect:
(1) clinical cure: fracture is satisfied to the line para-position, and the seriality callus formation is arranged, and the broken ends of fractured bone does not have tenderness, does not have the pain of impact, and functional rehabilitation is normal;
(2) take a turn for the better: para-position and to line still can, or the fracture para-position is not good, but functional rehabilitation is fair;
(3) do not heal: nonunion becomes local obviously deformity, dysfunction.
Four, therapeutic effect: in this clinical observation case, after taking medicine 30-50 days, 41 examples of fully recovering, 19 examples take a turn for the better.Toxic and side effects does not take place during the treatment.
Five, model case:
Case 1:
Zhang, man, 62 years old.Damage because of traffic accident, make right lower limb fracture of tibia and fibula, adopt external fixer to fix, do not see that the callus row was long in 4 months.Take the decoction two months of Chinese medicine composition of the present invention preparation, fracture line is fuzzy, continued to take medicine 1 month, and recovery from illness, external fixer takes down, and recovers normal.
Case 2:
High certain, man, 51 years old.Fall after drinking, chest lands, and feels chest pain afterwards, and the pain of can not getting up is afterwards made film and pointed out: the 3rd fracture of rib unbearably.Take the decoction 3 days of Chinese medicine composition of the present invention preparation, severe pain disappears; Continue clothes after 10 days, the clinical symptoms complete obiteration; Continuous clothes 1 month, x light show that fracture line disappears, and reaches recovery from illness.
Claims (1)
1. Chinese medicine composition for the treatment of fracture is characterized in that: its raw material of Chinese medicine is formed and weight proportion is: Herba Lycopodii 30g, Herba speranskiae tuberculatae 30g, Radix Angelicae Sinensis 20g, Radix Paeoniae Rubra 20g, Radix Notoginseng 20g, Flos Carthami 12g, Fructus Chaenomelis 12g, Ramulus Cinnamomi 15g, Rhizoma Drynariae 15g, Radix Dipsaci 15g, Caulis Spatholobi 15g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110425232 CN102512517B (en) | 2011-12-19 | 2011-12-19 | Traditional Chinese medicine composition for treating bone fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110425232 CN102512517B (en) | 2011-12-19 | 2011-12-19 | Traditional Chinese medicine composition for treating bone fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512517A CN102512517A (en) | 2012-06-27 |
| CN102512517B true CN102512517B (en) | 2013-09-11 |
Family
ID=46283770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110425232 Expired - Fee Related CN102512517B (en) | 2011-12-19 | 2011-12-19 | Traditional Chinese medicine composition for treating bone fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512517B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191211B (en) * | 2013-03-07 | 2014-04-16 | 苑克进 | Traditional Chinese medicine for treating lateral epicondylitis |
| CN103285208B (en) * | 2013-07-02 | 2014-10-01 | 河南省正骨研究院 | Traditional Chinese medicine preparation for treating early damage and preparation method thereof |
| CN103860614A (en) * | 2014-03-20 | 2014-06-18 | 龙秋荣 | Chinese medicinal preparation for rapid bone setting and preparation method thereof |
| CN103933285B (en) * | 2014-03-26 | 2017-06-06 | 高永学 | A kind of traditional Chinese medicine for oral administration prescription that can accelerate postop fracture healing |
| CN104312888A (en) * | 2014-10-08 | 2015-01-28 | 登封市绿之源农副产品开发有限公司 | Persimmon vinegar with capability of promoting reunion of fractured tendons and bones and preparation method of persimmon vinegar |
| CN107802723A (en) * | 2017-11-23 | 2018-03-16 | 毛垅 | A kind of medicine for treating fracture and preparation method thereof |
| CN113425775A (en) * | 2020-03-23 | 2021-09-24 | 朱照升 | Medicinal formula for relaxing muscles and tendons and promoting blood circulation and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101455756A (en) * | 2007-12-14 | 2009-06-17 | 刘敏静 | Traditional Chinese medicine preparation for treating bone fracture |
| CN101716266A (en) * | 2010-01-13 | 2010-06-02 | 孟照明 | Medicaments for treating fractures and preparation method thereof |
| CN101926867A (en) * | 2010-09-16 | 2010-12-29 | 赵锦秀 | Bone fracture recovering soup |
| CN101991672A (en) * | 2009-08-20 | 2011-03-30 | 魏平 | Medicinal liquor for treating herniated disk and hyperosteogeny as well as preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201911199T4 (en) * | 2009-03-27 | 2019-08-21 | Moleac Pte Ltd | Treatment to increase cell growth. |
-
2011
- 2011-12-19 CN CN 201110425232 patent/CN102512517B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101455756A (en) * | 2007-12-14 | 2009-06-17 | 刘敏静 | Traditional Chinese medicine preparation for treating bone fracture |
| CN101991672A (en) * | 2009-08-20 | 2011-03-30 | 魏平 | Medicinal liquor for treating herniated disk and hyperosteogeny as well as preparation method thereof |
| CN101716266A (en) * | 2010-01-13 | 2010-06-02 | 孟照明 | Medicaments for treating fractures and preparation method thereof |
| CN101926867A (en) * | 2010-09-16 | 2010-12-29 | 赵锦秀 | Bone fracture recovering soup |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512517A (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512517B (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN104147577B (en) | A kind of plaster for promoting growth of spur to treat fracture | |
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN102327380B (en) | Chinese medicinal composition for treating knee osteoarthritis | |
| CN102512565A (en) | Traditional Chinese medicine composition for treating lumbago due to kidney deficiency | |
| CN101099839A (en) | External-applied traditional Chinese medicine bag and using method thereof | |
| CN101607015A (en) | A kind of Chinese medicine composition for the treatment of ischemic necrosis of femoral head | |
| CN1977934A (en) | Medicinal liquor for treating cervix vertebra disease and lumbar disc protrusion and its preparing method | |
| CN103893380A (en) | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny | |
| CN102343008B (en) | Chinese medicinal composition for treating prolapse of lumbar intervertebral disc | |
| CN102670995A (en) | Group of pure traditional Chinese medicinal formula for treating cardiovascular and cerebrovascular diseases and preparation method of same | |
| CN101926867A (en) | Bone fracture recovering soup | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN103041261A (en) | Traditional Chinese medicine composition for treating heat type arthritis | |
| CN102283929A (en) | Chinese medicinal composition for treating talalgia | |
| CN100490880C (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN102988860B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102784212B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN105687570A (en) | Traditional Chinese medicinal composition for treating sciatica | |
| CN102499963B (en) | Traditional Chinese medicine compound for treating fracture | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN103330814A (en) | Traditional Chinese medicine composition for treating deficiency of kidney yang | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN102349983A (en) | Traditional Chinese medicine composition for treating ischemic apoplexia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU RENCHANG Free format text: FORMER OWNER: RONGCHENG RESEARCH INSTITUTE OF SCIENTIFIC + TECHNICAL INFORMATION Effective date: 20130801 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Renchang Inventor after: Cheng Yaqi Inventor after: Yang Xia Inventor after: Sun Shengbo Inventor before: Sun Shengbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: SUN SHENGBO TO: LIU RENCHANG CHENG YAQI YANG XIA SUN SHENGBO |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130801 Address after: 264300 No. 10 South Riverside street, Rongcheng, Shandong, Weihai Applicant after: Liu Renchang Address before: 264300 Rongcheng City, Shandong Province Cultural East Road, No. 20, No. Applicant before: Rongcheng Research Institute of Scientific & Technical Information |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130911 Termination date: 20131219 |